Furthermore, tumor-infiltrating CD8 T cells with decreased mitochondrial function and mass exhibit loss of antitumor immune responses and responses to PD-1 blockade, although these losses can be reversed by overexpression of PGC1α, the major factor in mitochondrial biosynthesis (156). The gene discussed is CD8A; the disease is neoplasm.